Aptamers Targeting Immune Checkpoints for Tumor Immunotherapy

Tumor immunotherapy has revolutionized cancer treatment by harnessing the immune system to recognize and eliminate malignant cells, with immune checkpoint inhibitors targeting programmed death receptor 1 (PD-1), programmed death-ligand 1 (PD-L1), and cytotoxic T-lymphocyte-associated protein-4 (CTLA...

Full description

Bibliographic Details
Published in:Pharmaceutics
Main Authors: Amir Mohammed Abker Abdu, Yanfei Liu, Rami Abduljabbar, Yunqi Man, Qiwen Chen, Zhenbao Liu
Format: Article
Language:English
Published: MDPI AG 2025-07-01
Subjects:
aptamers
immune checkpoints
cancer immunotherapy
Online Access:https://www.mdpi.com/1999-4923/17/8/948

Internet

https://www.mdpi.com/1999-4923/17/8/948

Similar Items